کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2487235 | 1114409 | 2009 | 10 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Relationship between P-glycoprotein activity measured in peripheral blood mononuclear cells and indinavir bioavailability in healthy volunteers
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
داروسازی، سم شناسی و علوم دارویی
اکتشاف دارویی
پیش نمایش صفحه اول مقاله

چکیده انگلیسی
Indinavir, a HIV-1 protease inhibitor, showed large inter-individual pharmacokinetic variability. It has been proposed as a substrate of P-glycoprotein (P-gp), an efflux transporter, that may contribute to limit indinavir bioavailability. A liquid formulation of indinavir was developed from indinavir capsules in order to study indinavir pharmacokinetics in healthy volunteers. Compartmental and noncompartmental analysis of indinavir plasma concentrations showed high inter-individual variability in terms of area under the curve (AUC) and maximal plasma concentration (Cmax). A significant negative association between AUC normalized to body weight (AUC Ã weight) and lymphocyte P-gp activity, using Rh123 efflux assay, was observed (p = 0.008; râ=ââ0.75). AUC normalized to elimination rate constant (AUC Ã beta) also showed a significant negative relationship with lymphocyte P-gp activity (p = 0.03, r = â0.64). Apparent clearance (CL/[F Ã weight]) and volume of distribution (VD/[F Ã weight]) showed a positive correlation with P-gp activity. Conversely, elimination rate constant did not correlate with P-gp activity. Although there is not enough evidence of a correlation between lymphocitary and intestinal function of P-gp, our results suggest a relationship between a P-gp phenotype marker, Rh123 efflux assay in lymphocytes, and indinavir bioavailability.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Pharmaceutical Sciences - Volume 98, Issue 1, January 2009, Pages 327-336
Journal: Journal of Pharmaceutical Sciences - Volume 98, Issue 1, January 2009, Pages 327-336
نویسندگان
Guillermo F. Bramuglia, Catalina M. Cortada, Verónica Curras, Christian Höcht, Fabián Buontempo, Gabriel Mato, Viviana Niselman, Modesto Rubio, Marta Carballo,